Biohm Technologies
Dr. Mahmoud Ghannoum is a prominent figure in the field of medical mycology, serving as the Director of Medical Mycology at Case Western Reserve University since 1996 and as a Professor at the same institution. In addition to their academic roles, Dr. Ghannoum co-founded BIOHM Health in October 2016, contributing to innovative health solutions. Dr. Ghannoum holds an Executive MBA in Biology Chemistry from the Weatherhead School of Management at Case Western Reserve University and possesses a PhD in Microbial Physiology and a Master's in Medicinal Chemistry, both from Loughborough University. The research center directed by Dr. Ghannoum focuses on the intersection of basic and translational research concerning fungi, emphasizing the journey from laboratory discoveries to clinical applications.
This person is not in any teams
Biohm Technologies
Biohm Technologies, based in Cleveland, OH, specializes in the development of targeted microbiome products leveraging the company’s extensive dataset of bacterial and fungal populations in the gut, a departure from the industry's predominant focus on bacteria alone. Biohm’s data-driven methodology, called Symbiont™, is the basis for the creation of award-winning ingredients validated through clinical trials. The company’s flagship ingredient is Mycohsa™, the first data-powered probiotic blend clinically shown to break down digestive biofilms and support optimal levels of both bacteria and yeasts for gut health. Biohm Technologies also offers its state-of-the-art, comprehensive microbiome gut testing kits as a private label solution for brands in the health and wellness space.